Gustavo Viana

Dr. Gustavo Viana

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RSRoberta Reis Soares
Roberta Reis Soares
JSJosé Marcio Fernandes da Silva
José Marcio Fernandes da Silva
BCBianca Cecheto Carlos
Bianca Cecheto Carlos
CFCamila Campos da Fonseca
Camila Campos da Fonseca
LSLaila Salomé Araújo de Souza
Laila Salomé Araújo de Souza
KSKézia Scopel
Kézia Scopel

7 November 2005 in Tetrahedron Letters
Verified
Journal Article
Closed access
GVGustavo Viana
Gustavo Viana
ISItamar C. Santos
Itamar C. Santos
RARosemeire B. Alves
Rosemeire B. Alves
LGLaurent Gil
Laurent Gil
CMChristian Marazano
Christian Marazano
RGRossimiriam P.F. Gil
Rossimiriam P.F. Gil

29 August 2012 in Molecules
Verified
Journal Article
Open access
PDF file
GSGraziele D. Da Silva
Graziele D. Da Silva
MSMarina G. Da Silva
Marina G. Da Silva
ESEstrela M. P. V. E. Souza
Estrela M. P. V. E. Souza
ABAndersson Barison
Andersson Barison
SSSarah C. Simões
Sarah C. Simões
JVJosé Augusto Ferreira Perez Villar
José Augusto Ferreira Perez Villar
A series of new chalcones substituted with azide/triazole groups were designed and synthesized, and their cytotoxic activity was evaluated in vitro against the HeLa cell line. O-Alkylation, Claisen-Schmidt condensation and Cu(I)-catalyzed cycloaddition of azides with terminal alkynes were applied in key steps. Fifteen compounds were tested against HeLa cells. Compound 8c was the most active molecule, with an IC50 value of 13.03 µM, similar to the value of cisplatin (7.37 µM).

10 December 2013 in Molecules
Verified
Journal Article
Open access
PDF file
MOMichael Eder De Oliveira
Michael Eder De Oliveira
GCGisele Cenzi
Gisele Cenzi
RNRenata Rachide Nunes
Renata Rachide Nunes
CACarla Regina Andrighetti
Carla Regina Andrighetti
DVDenia Mendes De Sousa Valadão
Denia Mendes De Sousa Valadão
FVFernando Varotti
Fernando Varotti
Herein, we report the antimalarial activity of nine 4-methoxychalcone derivatives 1a–i and an initial analysis of their ADMET properties. All compounds showed potent activity against the P. falciparum chloroquine-resistant clone W2, with IC50 values ranging from 1.96 µM to 10.99 µM, with moderate or low cytotoxicity against the HeLa cell line. The compound 1a (IC50 = 2.06 µM) had the best selectivity index (9.0). All the sulfonamide 4-metychalcone derivatives synthesized had cLogP values between 2 and 5 (mean value 3.79) and molecular weights (MWs) below 500. The substitution of the pyrrolidine group in 1i by a morpholine group in 1a reduced the cLogP value from 3.05 in compound 1i to 2.34 in compound 1a. Indeed, compound 1a had the highest LipE value. The binding free energy of compound 1a showed it to be the most optimal chalcone derivative for plasmepsin-2 (−7.3 Kcal/mol). The physicochemical properties and LipE analysis of the dataset allowed us to establish that compound 1a is the highest quality compound of the series and a potential oral lead candidate.

11 June 2011 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
FHFlaviane F. Hilário
Flaviane F. Hilário
RPRenata Cristina de Paula
Renata Cristina de Paula
MSMariana L. T. Silveira
Mariana L. T. Silveira
GVGustavo Viana
Gustavo Viana
RARosemeire B. Alves
Rosemeire B. Alves
FVFernando Varotti
Fernando Varotti

31 July 2014 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AGAlessandra Mirtes Marques Neves Gonçalves
Alessandra Mirtes Marques Neves Gonçalves
ALAline Brito De Lima
Aline Brito De Lima
MBMaria Cristina Da Silva Barbosa
Maria Cristina Da Silva Barbosa
LCLuiz Fernando De Camargos
Luiz Fernando De Camargos
JOJúlia Teixeira De Oliveira
Júlia Teixeira De Oliveira
GVGustavo Viana
Gustavo Viana
Cancer continues to be one of the most important health problems worldwide, and the identification of novel drugs and treatments to address this disease is urgent. During recent years, marine organisms have proven to be a promising source of new compounds with action against tumoral cell lines. Here, we describe the synthesis and anticancer activity of eight new 3-alkylpyridine alkaloid (3-APA) analogs in four steps and with good yields. The key step for the synthesis of these compounds is a Williamson etherification under phase-transfer conditions. We investigated the influence of the length of the alkyl chain attached to position 3 of the pyridine ring on the cytotoxicity of these compounds. Biological assays demonstrated that compounds with an alkyl chain of ten carbon atoms (4c and 5c) were the most active against two tumoral cell lines: RKO-AS-45-1 and HeLa. Micronucleus and TUNEL assays showed that both compounds are mutagenic and induce apoptosis. In addition, Compound 5c altered the cellular actin cytoskeleton in RKO-AS-45-1 cells. The results suggest that Compounds 4c and 5c may be novel prototype anticancer agents.